Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial: January 2020 Annals of Emergency Medicine Journal Club

William B. Stubblefield; D. Mark Courtney; Wesley H. Self

doi:10.1016/j.annemergmed.2019.11.010

Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial: January 2020 Annals of Emergency Medicine Journal Club

William B. Stubblefield, D. Mark Courtney, Wesley H. Self

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	116-118
Number of pages	3
Journal	Annals of emergency medicine
Volume	75
Issue number	1
DOIs	https://doi.org/10.1016/j.annemergmed.2019.11.010
State	Published - Jan 2020

ASJC Scopus subject areas

Emergency Medicine

Access to Document

10.1016/j.annemergmed.2019.11.010

Cite this

@article{61d92202b7d94fb3b86fdf74efdaac53,

title = "Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial: January 2020 Annals of Emergency Medicine Journal Club",

author = "Stubblefield, {William B.} and Courtney, {D. Mark} and Self, {Wesley H.}",

year = "2020",

month = jan,

doi = "10.1016/j.annemergmed.2019.11.010",

language = "English (US)",

volume = "75",

pages = "116--118",

journal = "Annals of emergency medicine",

issn = "0196-0644",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial

T2 - January 2020 Annals of Emergency Medicine Journal Club

AU - Stubblefield, William B.

AU - Courtney, D. Mark

AU - Self, Wesley H.

PY - 2020/1

Y1 - 2020/1

UR - http://www.scopus.com/inward/record.url?scp=85076458115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076458115&partnerID=8YFLogxK

U2 - 10.1016/j.annemergmed.2019.11.010

DO - 10.1016/j.annemergmed.2019.11.010

M3 - Article

C2 - 31866020

AN - SCOPUS:85076458115

SN - 0196-0644

VL - 75

SP - 116

EP - 118

JO - Annals of emergency medicine

JF - Annals of emergency medicine

IS - 1

ER -

Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial: January 2020 Annals of Emergency Medicine Journal Club

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this